Liposomal Bupivacaine Reduced Opioid Consumption Following Cesarean Section, Poster Says
A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.
Navigating the Oncology Specialty Patient Journey
In a conversation from this year's Healthcare Advocate Summit, Randy Falkenrath demystified the oncology medication management model and explained how specialty pharmacist can help patients access care.
Pharmaceutical Compounding, Storage of Faricimab Preserves Stability, Binding Properties
Maintaining the structure and function of antibody biologics like faricimab is critical for their administration via intravitreal injection (IVI), a common treatment approach for retinal diseases.
Immune Response, Metabolism Differences May Explain Increased Risk of Alzheimer’s Among Women
Study findings offer critical insight into the development of sex-specific treatment and prevention strategies for Alzheimer’s disease.
CGM Technology Bridges the Gap in Type 2 Diabetes Care for Underserved Patients
Increased health care access to devices like the continuous glucose monitor (CGM) could improve health outcomes for underserved patients who may otherwise be hindered from their use.
Study Links False-Positive Mammography Result to Increased Breast Cancer Risk
Findings detailing long-term breast cancer outcomes for women who received a false-positive result underscore the significance of false-positive results as a critical public health issue.
First At-Home Test for Chlamydia, Gonorrhea Approved by FDA
The FDA approval marks an important public health milestone in the ongoing effort to empower patients to take control of their own health.
Biden-Harris Administration to Establish Landmark Initiative on Women’s Health Research
The initiative will address the dire need to improve the lack of research on women’s health, one that has led to unfavorable health outcomes for the population.
Leverage Pharmacy Staff to Maximize Success When Launching New Clinical Services
Presenters at a NCPA 2023 session highlighted the importance of overcoming hesitations to implement new clinical services and taking an employee-centric approach in doing so.
Family and Peers Play Robust Roles in Influencing E-Tobacco Use, Study Finds
Understanding critical risk factors associated with the use of electronic nicotine delivery systems (ENDS) may help mitigate the harm dealt to youths by such devices.
Pfizer, BioNTech Release Positive Topline Data for Combination COVID-19/Flu Vaccine
The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.
FDA Approves First-of-its-Kind Subcutaneous Infliximab Biosimilar
Newly approved by the FDA, Celltrion’s infliximab-dyyb (Zymfentra) offers patients with inflammatory bowel disease a more innovative administrative approach to infliximab treatment.
2 Clarke Drive Cranbury, NJ 08512